ADHD – Related resources

Cochrane reviews

  • There is insufficient evidence on the effect of polyunsaturated fatty acids (PUFA) for ADHD in chilhren and adolescents [Evidence Level: D].
  • Methylphenidate, clonidine, guanfacine, desipramine and atomoxetine may reduce ADHD symptoms in children with tics [Evidence Level: C].
  • There is insufficient evidence on the effectiveness of meditation therapies for attention-deficit/hyperactivity disorder (ADHD) in children [Evidence Level: D].
  • Family therapy is probably not effective for attention-deficit disorder in children and adolescents. [Evidence Level: C].
  • There is no evidence for the effectiveness of dextroamphetamine for attention-deficit hyperactivity disorder (ADHD) in children with intellectual disability (ID) [Evidence Level: D].


  • Culpepper L. Primary care treatment of attention-deficit/hyperactivity disorder. J Clin Psychiatry 2006;67 Suppl 8():51-8.  [PMID:16961431]
  • Schonwald A. Update: attention deficit/hyperactivity disorder in the primary care office. Curr Opin Pediatr 2005 Apr;17(2):265-74.  [PMID:15800424]
  • Wolraich ML, Bickman L, Lambert EW, Simmons T, Doffing MA. Intervening to improve communication between parents, teachers, and primary care providers of children with ADHD or at high risk for ADHD. J Atten Disord 2005 Aug;9(1):354-68.  [PMID:16371681]

Copyright © 2020 Duodecim Medical Publications Limited.
ADHD – Related resources is a sample topic from the Evidence-Based Medicine Guidelines.

To view other topics, please or .

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. .